Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionFNCMX - Fidelity Nasdaq Composite Index Fund
Latest Disclosed Ownership72,608 shares
Latest Disclosed Value $ 1,675,792
FNCMX - Fidelity Nasdaq Composite Index Fund ownership in CPRX / Catalyst Pharmaceuticals, Inc.

On April 24, 2026 - FNCMX - Fidelity Nasdaq Composite Index Fund filed a NPORT-P form disclosing ownership of 72,608 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $1,675,793 USD as of February 28, 2026. The entity filed a previous NPORT-P on January 23, 2026 disclosing 72,608 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $2,286,426 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-02-28 NP CATALYST PHARMACEUTICALS EC US14888U1016 72,608 0 0.00 1,676 -1.41 0.0074
2026-01-23 2025-11-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 72,608 0 0.00 1,700 13.72 0.0073
2025-10-28 2025-08-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 72,608 296 0.41 1,495 -17.18 0.0071
2025-07-24 2025-05-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 72,312 -4,013 -5.26 1,805 3.26 0.0098
2025-04-25 2025-02-28 NP CATALYST PHARMACEUTICALS EC US14888U1016 76,325 0 0.00 1,747 3.74 0.0095
2025-01-27 2024-11-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 76,325 0 0.00 1,684 9.00 0.0090
2024-10-29 2024-08-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 76,325 13,166 20.85 1,546 51.32 0.0090
2024-07-26 2024-05-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 63,159 1,660 2.70 1,021 3.65 0.0063
2024-04-24 2024-02-29 NP CATALYST PHARMACEUTICALS EC US14888U1016 61,499 1,100 1.82 986 13.09 0.0063
2024-01-24 2023-11-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 60,399 0 0.00 872 2.71 0.0065
2023-10-27 2023-08-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 60,399 2,842 4.94 848 27.71 0.0064
2023-07-26 2023-05-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 57,557 0 0.00 665 -24.37 0.0056
2023-04-27 2023-02-28 NP CATALYST PHARMACEUTICALS EC US14888U1016 57,557 0 0.00 878 -9.02 0.0084
2023-01-26 2022-11-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 57,557 0 0.00 965 23.88 0.0090
2022-10-26 2022-08-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 57,557 2,577 4.69 779 97.22 0.0071
2022-07-29 2022-05-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 54,980 0 0.00 396 -7.71 0.0036
2022-04-27 2022-02-28 NP CATALYST PHARMACEUTICALS EC US14888U1016 54,980 0 0.00 429 11.46 0.0034
2022-01-25 2021-11-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 54,980 0 0.00 385 27.15 0.0027
2021-10-26 2021-08-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 54,980 6,493 13.39 303 12.69 0.0022
2021-07-22 2021-05-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 48,487 0 0.00 268 42.55 0.0022
2021-04-23 2021-02-28 NP CATALYST PHARMACEUTICALS EC US14888U1016 48,487 0 0.00 189 6.21 0.0017
2021-01-20 2020-11-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 48,487 -9,328 -16.13 177 -6.35 0.0017
2020-10-16 2020-08-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 57,815 0 0.00 190 -24.10 0.0019
2020-07-20 2020-05-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 57,815 0 0.00 249 2.47 0.0032
2020-04-24 2020-02-29 NP CATALYST PHARMACEUTICALS EC US14888U1016 57,815 0 0.00 243 -9.33 0.0034
2020-01-16 2019-11-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 57,815 57,815 268 0.0038
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.